COMMUNIQUÉS West-GlobeNewswire

Novartis study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer
15/06/2018
Comparison of Jakavi ® (ruxolitinib) vs. best available therapy presented at EHA suggests reduced risk of death in patients with inadequately controlled polycythemia vera (PV)[1] Additional data at EHA suggests earlier [...]
GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress
15/06/2018
Data from Four Additional Posters to be Presented, Including New Pharmacokinetic Data from HOPE-KIDS 1 Study Supporting Use of Weight-based Dosing Strategy for Voxelotor Clinical Trials in Children SOUTH SAN FRANCISCO, [...]
Atara Biotherapeutics’ Tab-cel™ Achieves Positive Long-Term Outcomes in Phase 2 Studies of Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas
15/06/2018
Findings presented at 23rd Congress of European Hematology Association Tab-cel™ demonstrated durable remissions and encouraging safety profile in patients with EBV+ PTLD who failed first line therapy Median survival in [...]
Shire plc : Rule 2.9 Announcement
15/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 15 June 2018 Shire [...]
BeiGene Provides Development Update and Presents Clinical Data on Zanubrutinib at the 23rd Congress of the European Hematology Association
15/06/2018
Investor Call Scheduled Today, June 15, 2018, at 8:00 am EDT CAMBRIDGE, Mass. and BEIJING, China, June 15, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on [...]
ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018
15/06/2018
LYON, France, June 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances [...]
Sandoz presents new long-term and switching data for biosimilars Zessly® (infliximab) and Erelzi® (etanercept) in rheumatoid arthritis
15/06/2018
Zessly ® (infliximab) matched the reference medicine in terms of safety and efficacy at 54 weeks, even in patients who switched from the reference medicine to Zessly[1] Switching from the reference medicine to Erelzi [...]
News Release: Notice of first General Meeting of the future EssilorLuxottica
15/06/2018
Notice of first General Meeting of the future EssilorLuxottica PDF version of the news release Charenton-le-Pont, France (June 15, 2018) - At its meeting of June 7, 2018, the Board of Directors of Essilor decided to [...]
Communiqué : Convocation à la première Assemblée Générale de la future société EssilorLuxottica
15/06/2018
Convocation à la première Assemblée Générale de la future société EssilorLuxottica Version PDF du communiqué Charenton-le-Pont, France (le 15 juin 2018) - Le Conseil d'administration d'Essilor, lors de sa réunion du 7 [...]
Zomedica Announces Changes to Commercialization Leadership Team
15/06/2018
ANN ARBOR, Mich., June 14, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced the [...]
Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering
14/06/2018
WEST CHESTER, Pa., June 14, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and Provides Conference Call Information
14/06/2018
Conference Call Scheduled for Friday, June 15 at 1:00 PM EDT NORTHVALE, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company [...]
Sorrento Therapeutics issues Chairman/CEO corporate update to stockholders
14/06/2018
SAN DIEGO, June 14, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Dear Sorrento Stockholders, It is with pride that I issue this mid-year update letter to our shareholders. Since the beginning of [...]
Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board
14/06/2018
TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”) (TSXV: PRN) (OTCQX:PRFMF) is pleased to announce the results of the votes on the matters considered at its Annual Meeting [...]
Reata Pharmaceuticals, Inc. Secures $125 Million Term Loan Facility
14/06/2018
IRVING, Texas, June 14, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced that it entered into an amended and [...]
Transparency notification
14/06/2018
Mechelen, Belgium; 14 June 2018; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency [...]
Transparency notification pursuant to Article 14 of the Law of May 2, 2007
14/06/2018
REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - June 14, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Kiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences Conference
14/06/2018
HAMILTON, Bermuda, June 14, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA) announced today that it will be presenting at the JMP Securities 2018 Life Sciences Conference on Thursday, June 21 st , [...]
AGTC Announces Expansion of Clinical and Regulatory Leadership Teams
14/06/2018
20+ Year Medical Affairs and Ophthalmology Veteran, Lanita C. Scott, M.D., Appointed as Vice President of Clinical Research and Medical Affairs Karen M. Carroll, RN, Named Vice President of Clinical Development [...]

Pages